Adam Hansard

Insider Reports History

Location
New York, NY
Signature
/s/ Shoshana Shendelman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam Hansard:

Company Role Class Num Shares Value Price $ Report Date Ownership
Applied Therapeutics, Inc. Chief Commercial Officer Common Stock 732,919 $3,950,433 $5.39 14 Mar 2024 Direct

Insider Reports Filed by Adam Hansard

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLT Applied Therapeutics, Inc. 14 Mar 2024 1 -$263,415 4 Chief Commercial Officer 18 Mar 2024, 18:00
APLT Applied Therapeutics Inc. 21 Dec 2023 1 $0 4 Chief Commercial Officer 22 Dec 2023, 20:01
APLT Applied Therapeutics Inc. 30 Nov 2023 1 -$1,901 4 Chief Commercial Officer 01 Dec 2023, 19:42
APLT Applied Therapeutics Inc. 27 Sep 2023 1 -$26,244 4 Chief Commercial Officer 29 Sep 2023, 21:02
APLT Applied Therapeutics Inc. 11 Jan 2023 2 -$4,090 4 Chief Commercial Officer 13 Jan 2023, 15:30
APLT Applied Therapeutics Inc. 02 Aug 2022 10 $0 4 Chief Commercial Officer 04 Aug 2022, 20:35
APLT Applied Therapeutics Inc. 13 Apr 2022 1 $0 4 Chief Commercial Officer 15 Apr 2022, 19:07
APLT Applied Therapeutics Inc. 07 Jan 2022 2 $0 4 Chief Commercial Officer 11 Jan 2022, 17:44
APLT Applied Therapeutics Inc. 14 Dec 2021 1 $0 4/A Chief Commercial Officer 11 Jan 2022, 17:41
APLT Applied Therapeutics Inc. 26 May 2021 1 -$53,105 4 Chief Commercial Officer 28 May 2021, 19:12